GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook
The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...
FTSE 100 Live 05 February: GSK shares surge on new guidance, gold at record price
An improved long-term sales target today revitalised GSK shares after their dismal 2024. The confidence in GSK’s drugs ...
Brand Watch: Three companies put their impacts on nature under a microscope. Here’s what they found
Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed to highlight the intuitive interconnectedness of the natural world; but it ...
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...